Avian influenza (H5N1) update: Role of the clinical microbiology laboratory

Laboratory Medicine

Volumn 42, Issue 5, 2011, Pages 291-298

  Loeffelholz, Michael J ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Avian influenza; Diagnosis; H5N1

Indexed keywords

AMANTADINE; INFLUENZA VACCINE; OSELTAMIVIR; RIMANTADINE; ZANAMIVIR;

2009 H1N1 INFLUENZA; ANTIGEN DETECTION; ARTICLE; CLINICAL LABORATORY; HUMAN; INFLUENZA A (H5N1); INFLUENZA VIRUS A H5N1; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PATHOGENESIS; SEROLOGY; VIRUS CULTURE; VIRUS STRAIN;

AVES; ORTHOMYXOVIRIDAE;

EID: 79955532374     PISSN: 00075027     EISSN: 19437730     Source Type: Journal    
DOI: 10.1309/LMOEB6A8Q9RXNYXJh     Document Type: Article

References (47)

1. Dushoff J, Plotkin JB, Viboud C, et al. Mortality due to influenza in the United States-An annualized regression approach using multiple-cause mortality data. Am J Epidemiol. 2006;163:181-187.
2. Centers for Disease Control and Prevention (CDC). Update: Novel influenza A (H1N1) virus infections-worldwide, May 6, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:453-458.
3. Claas EC, de Jong JC, van Beek R, et al. Human influenza virus A/Hong Kong/156/97 (H5N1) infection. Vaccine. 1998;16:977-978.
4. Duan L, Bahl J, Smith GJ, et al. The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. Virology. 2008;380:243-254.
5. Li Y, Shi J, Zhong G, et al. Continued evolution of H5N1 influenza viruses in wild birds, domestic poultry, and humans in China from 2004 to 2009. J Virol. 2010;84:8389-8397.
6. Kilpatrick AM, Chmura AA, Gibbons DW, et al. Predicting the global spread of H5N1 avian influenza. Proc Natl Acad Sci USA. 2006;103:19368-19373.
7. Nguyen T, Davis CT, Stembridge W, et al. Characterization of a highly pathogenic avian influenza H5N1 virus sublineage in poultry seized at ports of entry into Vietnam. Virology. 2009;387:250-256.
8. Loeffelholz MJ. Avian influenza A H5N1 virus. Clin Lab Med. 2010;30:1-20.
9. World Health Organization. Global alert and response (GAR)-confirmed human cases of avian influenza A (H5N1). Available at: www.who.int/csr/disease/avian_influenza/country/cases_table_2010_06_08/en/index.html. Accessed August 9, 2010.
10. van Riel D, den Bakker MA, Leijten LM, et al. Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses. Am J Pathol. 2010;176:1614-1618.
11. Wang H, Feng Z, Shu Y, et al. Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet. 2008;371:1427-1434.
12. Matrosovich MN, Matrosovich TY, Gray T, et al. Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci USA. 2004;101:4620-4624.
13. de Jong MD, Simmons CP, Thanh TT, et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006;12:1203-1207.
14. Writing Committee of the Second World Health Organization (WHO) Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus. Update on avian influenza A (H5N1) virus infection in humans. N Engl J Med. 2008;358:261-273.
15. Shu Y, Li CK, Li Z, et al. Avian influenza A(H5N1) viruses can directly infect and replicate in human gut tissues. J Infect Dis. 2010;201:1173-1177.
16. Horby P, Sudoyo H, Viprakasit V, et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect. 2010;138:1550-1558.
17. Le MTQ, Wertheim HFL, Nguyen HD, et al. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam. PLoS ONE. 2008;3:e3339.
18. Apisarnthanarak A, Kitphati R, Thongphubeth K, et al. Atypical avian influenza (H5N1). Emerg Inf Dis. 2004;10:1321-1324.
19. Uyeki TM. Global epidemiology of human infections with highly pathogenic avian influenza A (H5N1) viruses. Respirology. 2008;13:S2-S9.
20. de Jong MD, Tran TT, Truong HK, et al. Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med. 2005;353:2667-2672.
21. Prieto-Lara E, Llanos-Méndez A. Safety and immunogenicity of prepandemic H5N1 influenza vaccines: A systematic review of the literature. Vaccine. 2010:28:4328-4334.
22. Centers for Disease Control and Prevention. Updated interim guidance for laboratory testing of persons with suspected infection with highly pathogenic avian influenza (H5N1) virus in the United States. Available at: www.cdc.gov/flu/avian/professional/guidance-labtesting.htm. Accessed August 8, 2010.
23. American Society for Microbiology. Sentinel laboratory guidelines for suspected agents of bioterrorism and emerging infectious diseases-packing and shipping infectious substances. Available at: www.asm.org/images/pdf/PackingandShipping1-08.pdf. Accessed August 9, 2010.
24. Chan KH, Lam SY, Puthavathana P, et al. Comparative analytical sensitivities of six rapid influenza A antigen detection test kits for detection of influenza A subtypes H1N1, H3N2 and H5N1. J Clin Virol. 2007;38:169-171.
25. Sakai-Tagawa Y, Ozawa M, Tamura D, et al. Sensitivity of influenza rapid diagnostic tests to H5N1 and 2009 pandemic H1N1 viruses. J Clin Microbiol. 2010;48:2872-2877.
26. Fedorko DP, Nelson NA, McAuliffe JM, et al. Performance of rapid tests for detection of avian influenza A virus types H5N1 and H9N2. J Clin Microbiol. 2006;44:1596-1597.
27. Ginocchio CC, Zhang F, Manji R, et al. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol. 2009;45:191-195.
28. Landry ML, Cohen S, Ferguson D. Real-time PCR compared to Binax NOW and cytospin-immunofluorescence for detection of influenza in hospitalized patients. J Clin Virol. 2008;43:148-151.
29. Yuen KY, Chan PK, Peiris M, et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998;351:467-471.
30. Li IW, Chan KH, To KW, et al. Differential susceptibility of different cell lines to swine-origin influenza A H1N1, seasonal human influenza A H1N1, and avian influenza A H5N1 viruses. J Clin Virol. 2009;46:325-330.
31. Schultz-Cherry S, Dybdahl-Sissoko N, McGregor M, et al. Mink lung epithelial cells: Unique cell line that supports influenza A and B virus replication. J Clin Microbiol. 1998;36:3718-3720.
32. Chantratita W, Sukasem C, Kaewpongsri S, et al. Qualitative detection of avian influenza A (H5N1) viruses: A comparative evaluation of four real-time nucleic acid amplification methods. Mol Cell Probes. 2008;22:287-293.
33. Jayawardena S, Cheung CY, Barr I, et al. Loop-mediated isothermal amplification for influenza A (H5N1) virus. Emerg Infect Dis. 2007;13:899-901.
34. Mahony J, Chong S, Merante F, et al. Development of a respiratory virus panel test for detection of twenty human respiratory viruses by use of multiplex PCR and a fluid microbead-based assay. J Clin Microbiol. 2007;45:2965-2970.
35. Wang W, Ren P, Mardi S, et al. Design of multiplexed detection assays for identification of avian influenza A virus subtypes pathogenic to humans by SmartCycler real-time reverse transcription-PCR. J Clin Microbiol. 2009;47:86-92.
36. Clark RB, Lewinski MA, Loeffelholz MJ, et al. Cumitech 31A, Verification and Validation of Procedures in the Clinical Microbiology Laboratory. Washington, DC: ASM Press; 2009.
37. Stelzer-Braid S, Escott R, Baleriola C, et al. Proficiency of nucleic acid tests for avian influenza viruses, Australasia. Emerg Infect Dis. 2008;14:1126-1128.
38. Jia N, Wang SX, Liu YX, et al. Increased sensitivity for detecting avian influenza-specific antibodies by a modified hemagglutination inhibition assay using horse erythrocytes. J Virol Methods. 2008;153:43-48.
39. Noah DL, Hill H, Hines D, et al. Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure. Clin Vaccine Immunol. 2009;16:558-566.
40. Rowe T, Abernathy RA, Hu-Primmer J, et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays. J Clin Microbiol. 1999;37:937-943.
41. Stelzer-Braid S, Wong B, Robertson P, et al. A commercial ELISA detects high levels of human H5 antibody but cross-reacts with influenza A antibodies. J Clin Virol. 2008;43:241-243.
42. Wang W, Butler EN, Veguilla V, et al. Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies. J Virol Methods. 2008;153:111-119.
43. Prabakaran M, Ho HT, Prabhu N, et al. Development of epitope-blocking ELISA for universal detection of antibodies to human H5N1 influenza viruses. PLoS One. 2009;4:e4566.
44. Gall A, Hoffmann B, Harder T, et al. Design and validation of a microarray for detection, hemagglutinin subtyping, and pathotyping of avian influenza viruses. J Clin Microbiol. 2009;47:327-334.
45. Michael K, Harder TC, Mettenleiter TC, et al. Diagnosis and strain differentiation of avian influenza viruses by restriction fragment mass analysis. J Virol Methods. 2009;158:63-69.
46. Qi C, Tian XS, Chen S, et al. Detection of avian influenza virus subtype H5 using a biosensor based on imaging ellipsometry. Biosens Bioelectron. 2010;25:1530-1534.
47. Chen L, Sheng Z, Zhang A, et al. Quantum-dots-based fluoroimmunoassay for the rapid and sensitive detection of avian influenza virus subtype H5N1. Luminescence. 2010;25:419-423.